MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/mgg3.2237

Медицинская библиотека · Molecular genetics & genomic medicine · 2023

Clinically actionable secondary findings in 130 triads from sub-Saharan African families with non-syndromic orofacial clefts.

Oladayo Abimbola, Gowans Lord Jephthah Joojo, Awotoye Waheed, Alade Azeez, Busch Tamara, Naicker Thirona, Eshete Mekonen A, Adeyemo Wasiu L, Hetmanski Jacqueline B, Zeng Erliang, Adamson Olawale, Adeleke Chinyere, Li Mary, Sule Veronica, Kayali Sami, Olotu Joy, Mossey Peter A, Obiri-Yeboah Solomon, Buxo Carmen J, Beaty Terri, Taub Margaret, Donkor Peter, Marazita Mary L, Odukoya Oluwakemi, Adeyemo Adebowale A, Murray Jeffrey C, Prince Anya, Butali Azeez

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

INTRODUCTION

The frequency and implications of secondary findings (SFs) from genomic testing data have been extensively researched. However, little is known about the frequency or reporting of SFs in Africans, who are underrepresented in large-scale population genomic studies. The availability of data from the first whole-genome sequencing for orofacial clefts in an African population motivated this investigation.

METHODS

In total, 130 case-parent trios were analyzed for SFs within the ACMG SFv.3.0 list genes. Additionally, we filtered for four more genes (HBB, HSD32B, G6PD and ACADM).

RESULTS

We identified 246 unique variants in 55 genes; five variants in four genes were classified as pathogenic or likely pathogenic (P/LP). The P/LP variants were seen in 2.3% (9/390) of the subjects, a frequency higher than ~1% reported for diverse ethnicities. On the ACMG list, pathogenic variants were observed in PRKAG (p. Glu183Lys). Variants in the PALB2 (p. Glu159Ter), RYR1 (p. Arg2163Leu) and LDLR (p. Asn564Ser) genes were predicted to be LP.

CONCLUSION

This study provides information on the frequency and pathogenicity of SFs in an African cohort. Early risk detection will help reduce disease burden and contribute to efforts to increase knowledge of the distribution and impact of actionable genomic variants in diverse populations.

Для цитирования: Oladayo Abimbola, Gowans Lord Jephthah Joojo, Awotoye Waheed, Alade Azeez, Busch Tamara, Naicker Thirona, Eshete Mekonen A, Adeyemo Wasiu L, Hetmanski Jacqueline B, Zeng Erliang, Adamson Olawale, Adeleke Chinyere, Li Mary, Sule Veronica, Kayali Sami, Olotu Joy, Mossey Peter A, Obiri-Yeboah Solomon, Buxo Carmen J, Beaty Terri, Taub Margaret, Donkor Peter, Marazita Mary L, Odukoya Oluwakemi, Adeyemo Adebowale A, Murray Jeffrey C, Prince Anya, Butali Azeez. Clinically actionable secondary findings in 130 triads from sub-Saharan African families with non-syndromic orofacial clefts.. Molecular genetics & genomic medicine. 2023. DOI: 10.1002/mgg3.2237.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.